Toronto-based Flowr exits Australia, Uruguay, Spain cannabis markets
Toronto-headquartered cannabis company Flowr Corp. is slashing its workforce and pulling out of noncore markets - including Australia,…
News April 15
Latest In: Europe
Curaleaf gets $130M funding for stake in newly acquired global cannabis firm
Multistate cannabis operator Curaleaf Holdings secured $130 million in funding from an unidentified “strategic institutional investor” in exchange…
News April 7
Intellectual property takes on growing role in cannabis industry deals
Intellectual property is playing an increasingly important role in cannabis industry acquisitions and other deals as businesses look…
News April 5
Cannabis extractors are exploring THC remediation options
One is quick but expensive. The other is economical but slow - and tricky to get just right.…
News April 2
Curaleaf enters European cannabis market with $286 million acquisition of Emmac Life Sciences
Curaleaf Holdings said Tuesday it signed a $286 million definitive agreement to acquire London-based medical marijuana company Emmac…
News March 9
Aurora says its Danish cannabis has reached German pharmacies
A subsidiary of Canada’s Aurora Cannabis says its “made in Denmark” medical cannabis products have reached some Germany…
News February 23
How a $100M global cannabis deal came together over Zoom: Q&A with IMC’s Oren Shuster
Negotiating an international cannabis merger worth roughly $100 million is hard enough – but doing so during a…
News February 18
Canadian marijuana producer Tilray reports $271 million loss for year
Cannabis producer Tilray cut its annual loss to $271 million for 2020, an improvement from the Nanaimo, British…
News February 17
Hexo strikes deal to acquire Zenabis for CA$235 million, eyes European, Canadian cannabis markets
Ottawa, Ontario-headquartered cannabis producer Hexo Corp. on Tuesday entered a definitive agreement to buy struggling competitor Zenabis Global…
News February 16
Will GW’s multibillion-dollar sale ‘open floodgates’ to pharma-cannabis deal-making?
Jazz Pharmaceuticals' planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making…
News February 5
Latest Sponsored
